The Impact of Clinical Pharmacy Services on Patient Outcomes in Chronic Disease Management

Authors

  • Fadi Moqbil Alenazi
  • Hamad Salem Alsharari
  • Sahw Fahhad Alhazmi
  • Ali Salem Alhazmi
  • Salha M. Al-Dossary
  • Barakah S. Al-Shamlan
  • Faisal S. Al-Dakheel
  • Hamad Salem Alqahtani
  • Fahad Abdulrahman Hadi Alotaibi
  • Talag Rajeh Abdulwahab Alotaibi
  • Maged Mohammed Hamead Alotaibi
  • Mesfer A Alghamdi

DOI:

https://doi.org/10.63278/jicrcr.vi.386

Keywords:

controlling chronic diseases, Pharmacological therapy.

Abstract

Chronic illness possess about 60% of adults in the US suffer from, which accounts for 90% of the nation's yearly medical expenses. Pharmacological therapy accounted for 70% of outpatient medical visits in 2018, and over 860 million drugs were prescribed or administered in 2018. Long-term medication is a significant aspect of controlling chronic diseases (CDM).(Santo and Okeyode,2018).

Downloads

Published

2024-11-10

How to Cite

Alenazi, F. M., Alsharari, H. S., Alhazmi, S. F., Alhazmi, A. S., Al-Dossary, S. M., Al-Shamlan, B. S., … Alghamdi, M. A. (2024). The Impact of Clinical Pharmacy Services on Patient Outcomes in Chronic Disease Management . Journal of International Crisis and Risk Communication Research , 554–564. https://doi.org/10.63278/jicrcr.vi.386

Issue

Section

Articles